This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2008 Jan 17;358(3):291-2.

doi: 10.1056/NEJMe078215.

Clinical penetrance of hereditary hemochromatosis

Bruce R Bacon, Robert S Britton

PMID: 18199868
DOI: 10.1056/NEJMe078215

Editorial

Clinical penetrance of hereditary hemochromatosis

Bruce R Bacon et al. N Engl J Med. 2008.

. 2008 Jan 17;358(3):291-2.

doi: 10.1056/NEJMe078215.

Authors

Bruce R Bacon, Robert S Britton

PMID: 18199868
DOI: 10.1056/NEJMe078215

No abstract available

PubMed Disclaimer

Comment on

Iron-overload-related disease in HFE hereditary hemochromatosis.
Allen KJ, Gurrin LC, Constantine CC, Osborne NJ, Delatycki MB, Nicoll AJ, McLaren CE, Bahlo M, Nisselle AE, Vulpe CD, Anderson GJ, Southey MC, Giles GG, English DR, Hopper JL, Olynyk JK, Powell LW, Gertig DM. Allen KJ, et al. N Engl J Med. 2008 Jan 17;358(3):221-30. doi: 10.1056/NEJMoa073286. N Engl J Med. 2008. PMID: 18199861

Similar articles

Iron-overload-related disease in HFE hereditary hemochromatosis.
Allen KJ, Gurrin LC, Constantine CC, Osborne NJ, Delatycki MB, Nicoll AJ, McLaren CE, Bahlo M, Nisselle AE, Vulpe CD, Anderson GJ, Southey MC, Giles GG, English DR, Hopper JL, Olynyk JK, Powell LW, Gertig DM. Allen KJ, et al. N Engl J Med. 2008 Jan 17;358(3):221-30. doi: 10.1056/NEJMoa073286. N Engl J Med. 2008. PMID: 18199861
Clinical consequences of iron overload in hemochromatosis homozygotes.
Ajioka RS, Kushner JP. Ajioka RS, et al. Blood. 2003 May 1;101(9):3351-3; discussion 3354-8. doi: 10.1182/blood-2002-11-3453. Blood. 2003. PMID: 12707221 Review. No abstract available.
Hemochromatosis and iron-overload screening in a racially diverse population.
Adams PC, Reboussin DM, Barton JC, McLaren CE, Eckfeldt JH, McLaren GD, Dawkins FW, Acton RT, Harris EL, Gordeuk VR, Leiendecker-Foster C, Speechley M, Snively BM, Holup JL, Thomson E, Sholinsky P; Hemochromatosis and Iron Overload Screening (HEIRS) Study Research Investigators. Adams PC, et al. N Engl J Med. 2005 Apr 28;352(17):1769-78. doi: 10.1056/NEJMoa041534. N Engl J Med. 2005. PMID: 15858186
Case report of a patient with non-alcoholic fatty liver disease, moderate iron overload who is homozygous for the S65C mutation in the HFE1 gene.
Bernard PH, Ged C, Faivre E, Legac G, Bioulac-Sage P, Cassaigne A, de Verneuil H. Bernard PH, et al. Eur J Med Genet. 2005 Apr-Jun;48(2):195-8. doi: 10.1016/j.ejmg.2005.01.021. Epub 2005 Feb 12. Eur J Med Genet. 2005. PMID: 16053912 No abstract available.
Genetic predisposition to iron overload: prevalence and phenotypic expression of hemochromatosis-associated HFE-C282Y gene mutation.
Distante S. Distante S. Scand J Clin Lab Invest. 2006;66(2):83-100. doi: 10.1080/00365510500495616. Scand J Clin Lab Invest. 2006. PMID: 16537242 Review. No abstract available.

See all similar articles

Cited by

MRI-Based Iron Phenotyping and Patient Selection for Next-Generation Sequencing of Non-Homeostatic Iron Regulator Hemochromatosis Genes.
Viveiros A, Schaefer B, Panzer M, Henninger B, Plaikner M, Kremser C, Franke A, Franzenburg S, Hoeppner MP, Stauder R, Janecke A, Tilg H, Zoller H. Viveiros A, et al. Hepatology. 2021 Nov;74(5):2424-2435. doi: 10.1002/hep.31982. Epub 2021 Jul 13. Hepatology. 2021. PMID: 34048062 Free PMC article.
Do pregnancies reduce iron overload in HFE hemochromatosis women? results from an observational prospective study.
Scotet V, Saliou P, Uguen M, L'Hostis C, Merour MC, Triponey C, Chanu B, Nousbaum JB, Le Gac G, Ferec C. Scotet V, et al. BMC Pregnancy Childbirth. 2018 Feb 17;18(1):53. doi: 10.1186/s12884-018-1684-6. BMC Pregnancy Childbirth. 2018. PMID: 29454332 Free PMC article.
Factors influencing disease phenotype and penetrance in HFE haemochromatosis.
Rochette J, Le Gac G, Lassoued K, Férec C, Robson KJ. Rochette J, et al. Hum Genet. 2010 Sep;128(3):233-48. doi: 10.1007/s00439-010-0852-1. Epub 2010 Jul 6. Hum Genet. 2010. PMID: 20607553 Review.
Association of Multiple Biomarkers of Iron Metabolism and Type 2 Diabetes: The EPIC-InterAct Study.
Podmore C, Meidtner K, Schulze MB, Scott RA, Ramond A, Butterworth AS, Di Angelantonio E, Danesh J, Arriola L, Barricarte A, Boeing H, Clavel-Chapelon F, Cross AJ, Dahm CC, Fagherazzi G, Franks PW, Gavrila D, Grioni S, Gunter MJ, Gusto G, Jakszyn P, Katzke V, Key TJ, Kühn T, Mattiello A, Nilsson PM, Olsen A, Overvad K, Palli D, Quirós JR, Rolandsson O, Sacerdote C, Sánchez-Cantalejo E, Slimani N, Sluijs I, Spijkerman AM, Tjonneland A, Tumino R, van der A DL, van der Schouw YT, Feskens EJ, Forouhi NG, Sharp SJ, Riboli E, Langenberg C, Wareham NJ. Podmore C, et al. Diabetes Care. 2016 Apr;39(4):572-81. doi: 10.2337/dc15-0257. Epub 2016 Feb 9. Diabetes Care. 2016. PMID: 26861925 Free PMC article.
Evidence for the high importance of co-morbid factors in HFE C282Y/H63D patients cared by phlebotomies: results from an observational prospective study.
Saliou P, Le Gac G, Mercier AY, Chanu B, Guéguen P, Mérour MC, Gourlaouen I, Autret S, Le Maréchal C, Rouault K, Nousbaum JB, Férec C, Scotet V. Saliou P, et al. PLoS One. 2013 Dec 5;8(12):e81128. doi: 10.1371/journal.pone.0081128. eCollection 2013. PLoS One. 2013. PMID: 24339903 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information